Fresenius Medical Care AG & Co. KGaA (ADR) (NYSE:FMS)
| CAPS Rating |
|
|---|
FMS
VS S&P 500 (SPY)
FMS News and Commentary
- Fresenius' 1Q Mixed, Profit Up - Analyst Blog – NASDAQ
- A Little Confidence Goes a Long Way – The Motley Fool
- 2nd UPDATE: Fresenius SE Offers EUR3.1 Billion For Rhoen-Klinikum – SmartMoney
- UPDATE: Fresenius SE Offers EUR3.1 Billion For Rhoen-Klinikum – SmartMoney
- Fresenius SE Raises 2012 Outlook After Strong First Quarter – SmartMoney
- Fresenius Medical Care 1Q Net Profit $370 Million, Backs Outlook – SmartMoney
- Is Affymax the Perfect Stock? – The Motley Fool
- A Fast Growing Emerging Market Healthcare Story – Blogs @ The Motley Fool
- Drug Approved, Sales Battle Begins – The Motley Fool
How do you think FMS will perform against the market?
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
181
Outperform
4
Underperform
All-Star Players
44
Outperform
0
Underperform
Wall Street
12
Outperform
0
Underperform
RSS Headlines
Fool UK
